Join the 'Dexasol' group to help and get support from people like you.
Posted 18 Apr 2017 by Drugs.com
TUESDAY, April 18, 2017 – Researchers seeking new sore throat treatments report only modest success with a single dose of a steroid medication. Concerns about growing bacterial resistance to antibiotics have led scientists to look for alternative therapies for sore throat, a common reason for doctor visits. In this new British study, a steroid medication led to improvement in about one-third of patients with sore throat. But, two U.S. physicians said they aren't rushing to prescribe the drugs on the basis of these results. Steroid treatment "might mask a more serious problem. That's really pretty important," said Dr. Robert Centor, a professor of internal medicine at the University of Alabama at Birmingham. "Most sore throats are relatively simple, but some are relatively dangerous, and people can die or end up in the ICU," said Centor, who wasn't involved in the study. "Steroids could ... Read more
Related support groups: Prednisone, Methylprednisolone, Medrol, Dexamethasone, Sore Throat, Decadron, TobraDex, Solu-Medrol, Ciprodex, Medrol Dosepak, MethylPREDNISolone Dose Pack, Depo-Medrol, Maxitrol, Ozurdex, Dexamethasone/Tobramycin, Deltasone, Dexamethasone/Neomycin/Polymyxin B, Tobradex ST, Maxidex, Decadron Tablets
Posted 6 Oct 2016 by Drugs.com
THURSDAY, Oct. 6, 2016 – Adding a newer drug to a standard treatment for advanced cases of multiple myeloma may significantly boost patients' chances of a response and even recovery, a new clinical trial finds. Of patients given the drug, called daratumumab, 43 percent had a complete response – meaning there were no signs of the cancer left. That compared with 19 percent of patients who received a standard drug duo alone. And over 13.5 months, the daratumumab combination cut patients' risk of dying or seeing their cancer progress by 63 percent, the study found. Researchers called the results "unprecedented" for patients like these. All had relapsed or refractory myeloma – which means the cancer had either come back or failed to respond to the previous treatment. "It is very likely that (this regimen) will be rapidly adopted by practicing physicians," said lead researcher Dr. Meletios ... Read more
Related support groups: Dexamethasone, Decadron, Multiple Myeloma, Revlimid, TobraDex, Ciprodex, Maxitrol, Dexamethasone/Tobramycin, Osteolytic Bone Lesions of Multiple Myeloma, Ozurdex, Decadron Tablets, Tobradex ST, Dexamethasone/Neomycin/Polymyxin B, Maxidex, Lenalidomide, Dexpak Taperpak, Neo-Poly-Dex, Adrenocot LA, Dexamethasone/Neomycin, Adrenocot